JAGSONPAL PHARMACEUTICALS
Back to Balance Sheet
|
JAGSONPAL PHARMACEUTICALS Last 5 Year Total Non-Current Liabilities History
[Standalone]
| Mar2026 | Mar2025 | Mar2024 | Mar2023 | Mar2022 | |
|---|---|---|---|---|---|
| Total Non-Current Liabilities | ₹12 Cr | ₹12 Cr | ₹18 Cr | ₹8.49 Cr | ₹4.49 Cr |
What is the latest Total Non-Current Liabilities ratio of JAGSONPAL PHARMACEUTICALS ?
| Year | Total Non-Current Liabilities |
|---|---|
| Mar2026 | ₹12 Cr |
| Mar2025 | ₹12 Cr |
| Mar2024 | ₹18 Cr |
| Mar2023 | ₹8.49 Cr |
| Mar2022 | ₹4.49 Cr |
How is Total Non-Current Liabilities of JAGSONPAL PHARMACEUTICALS Trending?
| Years | Total Non-Current Liabilities | % Change | |
|---|---|---|---|
| Mar2026 | ₹12 Cr | -1.60 | |
| Mar2025 | ₹12 Cr | -31.49 | |
| Mar2024 | ₹18 Cr | 113.41 | |
| Mar2023 | ₹8.49 Cr | 88.81 | |
| Mar2022 | ₹4.49 Cr | - | |
Compare Total Non-Current Liabilities of peers of JAGSONPAL PHARMACEUTICALS
| Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
| JAGSONPAL PHARMACEUTICALS | ₹1,571.8 Cr | -0.6% | 2.3% | -0.5% | Stock Analytics | |
| SUN PHARMACEUTICAL INDUSTRIES | ₹451,339.0 Cr | -1.6% | -2.5% | 21.4% | Stock Analytics | |
| DIVIS LABORATORIES | ₹254,068.0 Cr | 1.5% | 12.8% | 48.7% | Stock Analytics | |
| TORRENT PHARMACEUTICALS | ₹188,767.0 Cr | -0.9% | -0.8% | 35.3% | Stock Analytics | |
| CIPLA | ₹111,804.0 Cr | -1.6% | -5.2% | -11.7% | Stock Analytics | |
| DR REDDYS LABORATORIES | ₹96,113.4 Cr | -2.2% | -2.3% | -8.2% | Stock Analytics | |
JAGSONPAL PHARMACEUTICALS Share Price vs Sensex
| Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
| JAGSONPAL PHARMACEUTICALS | -0.6% |
2.3% |
-0.5% |
| SENSEX | -1.8% |
-3.7% |
-5.7% |
You may also like the below Video Courses